Interested Person Transaction::(2) THE RESULTANT JOINT VENTURE IN TIANJIN TAIPING MEDICINE AS AN INTERESTED PERSON TRANSACTION

Issuer & Securities

Issuer/ Manager: TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED
Securities: TIANJIN PHARM DA REN TANG GRP - CNE100000924 - T14
Stapled Security: No

Announcement Title: Interested Person Transaction
Date &Time of Broadcast: 11-Sep-2024 20:33:56
Status: New
Announcement Sub Title: (2) THE RESULTANT JOINT VENTURE IN TIANJIN TAIPING MEDICINE AS AN INTERESTED PERSON TRANSACTION
Announcement Reference: SG240911OTHRDYBI
Submitted By (Co./ Ind. Name): Jiao Yan
Designation: Secretary to the Board
Description (Please provide a detailed description of the event in the box below): (1) THE PROPOSED CAPITAL INJECTION INTO TIANJIN PHARMACEUTICAL GROUP TAIPING MEDICINE CO., LTD. BY THE COMPANY THROUGH THE TRANSFER OF THE 100% EQUITY INTEREST IN THE REGISTERED CAPITAL OF TIANJIN ZHONGXIN MEDICINE CO., LTD. TO TIANJIN PHARMACEUTICAL GROUP TAIPING MEDICINE CO., LTD. AND THE PROPOSED ENTRY INTO A CAPITAL INJECTION AGREEMENT IN RELATION THERETO AS AN INTERESTED PERSON TRANSACTION; AND
(2) THE RESULTANT JOINT VENTURE IN TIANJIN PHARMACEUTICAL GROUP TAIPING MEDICINE CO., LTD. AS AN INTERESTED PERSON TRANSACTION

Interested Person Details: For the purposes of the Proposed Capital Injection, both TJZX Medicine and Taiping Medicine are valued based on the appraised values of their net assets. Accordingly, the Injection Amount is based on the appraised value of the net assets of TJZX Medicine, being RMB RMB493,617,700. Upon completion of the Proposed Capital Injection, it is envisaged that the Company and TPH will hold 43.35% and 56.65% equity interest in Taiping Medicine respectively. Consequently, the completion of the Proposed Capital Injection will result in the Company establishing a joint venture in Taiping Medicine with TPH (the Proposed Joint Venture , together with the Proposed Capital Injection and the Proposed Provision of Guarantee, the Proposed IPTs ).

Total size =501K